undamentalytics Newsletter

Arvinas, Inc. cash flow statement

In fiscal 2025, Arvinas, Inc.'s operations generated −$274m of cash; it spent $1.9m on capital projects, leaving free cash flow of −$276m. It returned $91.9m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Arvinas, Inc.: cash flow statement, annual
Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations5−16−41−90559−274−348−259−274−207
Depreciation and amortisation0123565533
Stock-based pay0122030577672884437
Capital spending1366573222
Free cash flow4−19−47−96555−280−351−261−276−209
Free cash flow after stock pay4−31−67−126498−356−422−349−320−245
Share buybacks——————0092—
Shares issued0115138—1,300—————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ARVN vs IOVAADPT vs ARVNARVN vs VCELARVN vs VIR

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Arvinas, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Arvinas, Inc.